Rhythm Pharmaceuticals, Inc. RYTM
110.68 USD +24.24 (+28.04%)
At closeNov 4, 2026, 4:00 PM EST
109.22 -1.46 -1.32%
After hours · Nov 4, 4:00 PM ET
85.04 Day range 110.68
74.50 52-week range 122.20
- YTD
- +3.40%
- 1 year
- +5.42%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 140.29 +26.8% upside
Now 110.68
- Target (low)
- 120.00
- Target (mean)
- 140.29
- Target (high)
- 160.00
Ratings (0m) 19 17 buy · 2 hold · 0 sell
- Strong buy5
- Buy12
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 19
- 1 month ago 19
- 2 months ago 18
- 3 months ago 17
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.72513 | -0.93 – -0.57 | -0.73 | +0.7% | 108.37M | +89.3% | 12 |
| Next quarter | -0.68871 | -0.91484 – -0.45 | -0.83 | +17.0% | 110.99M | +84.6% | 4 |
| Current year | -3.05 | -3.36 – -2.82 | -3.11 | +1.9% | 329.79M | +73.8% | 12 |
| Next year | -0.65081 | -2.45 – 0.49 | -3.05 | +78.7% | 573.38M | +73.9% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Nov 3, 2026 | Needham | Maintained | Buy | Buy |
| Oct 16, 2026 | William Blair | Initiated | — | Outperform |
| Oct 15, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 28, 2026 | Deutsche Bank | Initiated | — | Hold |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 5, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jul 27, 2026 | JP Morgan | Initiated | — | Overweight |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 16, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 15, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 7, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 6, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 23, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 20, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 20, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 20, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Mar 18, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 17, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 17, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 17, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Mar 17, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 17, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 17, 2026 | Needham | Maintained | Buy | Buy |
| Mar 12, 2026 | Wells Fargo | Maintained | Overweight | Overweight |